Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature. Issue 12 (December 2022)
- Record Type:
- Journal Article
- Title:
- Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature. Issue 12 (December 2022)
- Main Title:
- Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature
- Authors:
- Shirane, Shuichi
Najima, Yuho
Fukushima, Kazuaki
Sekiya, Noritaka
Funata, Nobuaki
Kishida, Yuya
Nagata, Akihito
Yamada, Yuta
Konishi, Tatsuya
Kaito, Satoshi
Kurosawa, Shuhei
Yoshifuji, Kota
Uchida, Tomoyuki
Inamoto, Kyoko
Shingai, Naoki
Toya, Takashi
Igarashi, Aiko
Shimizu, Hiroaki
Kobayashi, Takeshi
Kakihana, Kazuhiko
Sakamaki, Hisashi
Ohashi, Kazuteru
Horiguchi, Shin-ichiro
Hishima, Tsunekazu
Doki, Noriko - Abstract:
- Abstract: Invasive mucormycosis is a refractory fungal infection. Central nervous system (CNS) mucormycosis is a rare complication caused by infiltration from the paranasal sinuses or hematogenous dissemination. Here, we present a case of a brain abscess, due to mucormycosis, diagnosed using burr craniotomy. A 25-year-old Japanese woman with relapsed-refractory acute lymphoblastic leukemia underwent cord blood transplantation (CBT). The patient experienced prolonged and profound neutropenia, and oral voriconazole was administered as primary antifungal prophylaxis. The patient received a conditioning regimen on day −11 and complained of aphasia and right hemiparesis on day −6. Magnetic resonance imaging (MRI) revealed a T2-weighted high-intensity area in the left frontal cortex. A brain abscess was suspected, and liposomal amphotericin B (L-AMB) administration was started. The patient underwent CBT as scheduled and underwent neutrophil engraftment on day 14. Although the patient achieved complete remission on day 28, her consciousness level gradually deteriorated. MRI revealed an enlarged brain lesion with a midline shift sign, suggesting brain herniation. Craniotomy was performed to relieve intracranial pressure and drain the abscess on day 38, and a diagnosis of cerebral mucormycosis was confirmed. The L-AMB dose was increased to 10 mg/kg on day 43. Although the patient's consciousness level improved, she died of hemorrhagic cystitis and aspiration pneumonia. CerebralAbstract: Invasive mucormycosis is a refractory fungal infection. Central nervous system (CNS) mucormycosis is a rare complication caused by infiltration from the paranasal sinuses or hematogenous dissemination. Here, we present a case of a brain abscess, due to mucormycosis, diagnosed using burr craniotomy. A 25-year-old Japanese woman with relapsed-refractory acute lymphoblastic leukemia underwent cord blood transplantation (CBT). The patient experienced prolonged and profound neutropenia, and oral voriconazole was administered as primary antifungal prophylaxis. The patient received a conditioning regimen on day −11 and complained of aphasia and right hemiparesis on day −6. Magnetic resonance imaging (MRI) revealed a T2-weighted high-intensity area in the left frontal cortex. A brain abscess was suspected, and liposomal amphotericin B (L-AMB) administration was started. The patient underwent CBT as scheduled and underwent neutrophil engraftment on day 14. Although the patient achieved complete remission on day 28, her consciousness level gradually deteriorated. MRI revealed an enlarged brain lesion with a midline shift sign, suggesting brain herniation. Craniotomy was performed to relieve intracranial pressure and drain the abscess on day 38, and a diagnosis of cerebral mucormycosis was confirmed. The L-AMB dose was increased to 10 mg/kg on day 43. Although the patient's consciousness level improved, she died of hemorrhagic cystitis and aspiration pneumonia. Cerebral mucormycosis should be suspected if neurological symptoms are observed in stem cell transplant recipients. Prompt commencement of antifungal therapy and debridement are crucial because mucormycosis has a poor prognosis. … (more)
- Is Part Of:
- Journal of infection and chemotherapy. Volume 28:Issue 12(2022)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 28:Issue 12(2022)
- Issue Display:
- Volume 28, Issue 12 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 12
- Issue Sort Value:
- 2022-0028-0012-0000
- Page Start:
- 1658
- Page End:
- 1662
- Publication Date:
- 2022-12
- Subjects:
- Cerebral mucormycosis -- Cord blood transplantation -- Acute lymphoblastic leukemia
Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2022.08.003 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23978.xml